Association Between Inpatient Steps Per Day and Patient Functional Status/Disposition

NCT ID: NCT03595605

Last Updated: 2020-05-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

51 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-16

Study Completion Date

2019-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will incorporate the use of wearable actigraphy devices (Fitbit) on research participants admitted to medicine inpatient units at Tisch Hospital and/or NYU Brooklyn. The investigator's sample size will be 600 randomized into two groups, with basic inclusion criteria including age greater than 65 years and pre-hospital ambulatory status. While both groups will be monitored in terms of their activity (specifically pedometer data), the intervention group will have twice daily encouragement of ambulation. Once a subject is enrolled, data will be collected daily and at time of discharge.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Medicine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FitBit Group

Will receive a wearable device (FitBit) designed to track number of steps for the duration of their hospital stay. They will receive nudges twice/day to ambulate

Group Type EXPERIMENTAL

Ambulation

Intervention Type BEHAVIORAL

This group will be encouraged twice daily to ambulate

Control Group-Standard of Care

300 subjects who will receive usual standard of care on a general inpatient medicine unit with the addition of a wearable device (FitBit) to track usual mobility in this setting. will complete their admission without push for increased activity (although having the device may influence their steps taken).

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type OTHER

Care as usual at inpatient NYU Langone

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ambulation

This group will be encouraged twice daily to ambulate

Intervention Type BEHAVIORAL

Standard of Care

Care as usual at inpatient NYU Langone

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admitted to acute inpatient medicine unit
* Ambulatory without assistive device prior to hospitalization
* Medical clearance to ambulate on the unit
* Active MyChart account or willing to activate MyChart account
* iOS or Android device

Exclusion Criteria

* Patients less than or equal to 65 years old
* Not Admitted to acute inpatient medicine unit
* Ambulatory with assistive device prior to hospitalization
* No Medical clearance to ambulate on the unit
* Inactive MyChart account and not willing to activate MyChart account
* No iOS or Android device

In addition, an individual who meets any of the following criteria will be excluded from participation in this study:

* Oxygen requirement at rest
* Lower extremity prosthesis
* Admitted for joint replacement surgery
* History of frequent falls
* Admitted for syncope.
* If patients have specifically opted out of being contacted about research (visible in the Epic header while in their chart)
* Admitted from nursing home
Minimum Eligible Age

66 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NYU Langone Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gavriil Ilizarov

Role: PRINCIPAL_INVESTIGATOR

NYU Langone Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New York University School of Medicine

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-01792

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fall Prevention Program for Older Adults
NCT00714051 COMPLETED PHASE1/PHASE2